Merck & Co., Inc. (MRK) NYSE

103.15

+2.06(+2.04%)

Updated at December 22 11:50AM

Currency In USD

Valuation

Market Cap251.88B
Enterprise Value276.91B
P/E Ratio13.46
PEG Ratio0.82
Price/Sales Ratio4.01
Price/Book Ratio4.94
Enterprise/Revenue4.37
Enterprise/EBITDA10.73

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.3
Operating Margin0.36

Management Effectiveness

Return On Assets0.17
Return On Equity0.39

Income Statement

Revenue64.17B
Revenue/Share25.71
Gross Profit48.98B
EBITDA25.71B
Net Income17.12B
Diluted EPS6.74

Balance Sheet

Total Cash18.21B
Total Cash/Share7.29
Total Debt41.37B
Total Debt/Equity0.8
Current Ratio1.66
Book Value Per Share20.76

Price History

52-Week Change3.31
52-Week High105.84
52-Week Low73.31
Moving Average 50 Days92.95
Moving Average 200 Days85.2

Statistics

Average Volume14.03M
Shares Outstanding2.51B
% Held by Institutions77.68

Dividend And Splits

Trailing Annual Dividend Rate3.28
Trailing Annual Dividend Yield3.2
Payout Ratio0.43
Last Split Factor131:125
Last Split DateJune 03, 2021